Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.0B | 8.0B | 9.3B | 8.3B |
Cost of revenue | 6.3B | 5.5B | 6.8B | 6.5B |
Gross profit | 783M | 2.6B | 2.5B | 1.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 299M | 241M | 264M | 283M |
Other operating expenses | 299M | 300M | 272M | 268M |
Operating income | 185M | 976M | 2.0B | 1.3B |
Non operating interest income | ||||
Income | 85M | 105M | 112M | 112M |
Expense | 219M | 225M | 206M | 243M |
Other income expense | — | — | — | — |
Pretax income | 239M | 608M | 1.9B | 1.1B |
Tax provision | 63M | 216M | 474M | 224M |
Net income | 176M | 392M | 1.4B | 909M |
Basic EPS | 0.0 | — | 0.3 | 0.2 |
Diluted EPS | 0.0 | — | 0.3 | 0.2 |
Basic average shares | 4.8B | — | 4.9B | 4.9B |
Diluted average shares | 4.8B | — | 4.9B | 4.9B |
EBITDA | 377M | 907M | 2.2B | 1.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |